KIM
ABBV icon

Kestra Investment Management’s AbbVie ABBV Stock Holding History

Kestra Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Sell
10,645
-491
-4% -$106K 0.05% 114
2026
Q1 		$2.42M Buy
11,136
+5,017
+82% +$1.11M 0.04% 122
2025
Q4 		$1.4M Sell
6,119
-84
-1% -$19.1K 0.03% 156
2025
Q3 		$1.44M Sell
6,203
-643
-9% -$131K 0.04% 159
2025
Q2 		$1.27M Sell
6,846
-2,523
-27% -$469K 0.04% 159
2025
Q1 		$1.96M Buy
9,369
+2,261
+32% +$440K 0.06% 98
2024
Q4 		$1.26M Buy
7,108
+1,579
+29% +$290K 0.05% 115
2024
Q3 		$1.09M Buy
+5,529
New +$1.03M 0.05% 113

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kestra Investment Management's ABBV Position: Q2 2026 in Review

Kestra Investment Management reduced its AbbVie (ABBV) stake by 4.4% in Q2 2026, selling an estimated $106K and leaving 10,645 shares worth $2.68M. The position accounts for 0.05% of the portfolio, ranked #114.

Kestra Investment Management first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kestra Investment Management held 10,645 shares of AbbVie worth $2.68M as of Q2 2026.
  • Kestra Investment Management sold 491 AbbVie shares in Q2 2026, an estimated $106K.
  • AbbVie made up 0.05% of Kestra Investment Management's portfolio in Q2 2026, its #114 holding.
  • Kestra Investment Management first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.